Axogen Inc.

NASDAQ:AXGN 4:00:00 PM EDT

6.52

-0.35 (-5.10%)

6:51:37 PM EDT: $6.50 -0.02 (-0.31%)

Market Cap (Intraday)	281.69M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	38.35

See more stats

Estimates Current Quarter

Revenue	$41.96 Million
Adjusted EPS	-$0.07

See more estimates

10-Day MA	$6.91
50-Day MA	$8.39
200-Day MA	$7.10

See more pivots

Axogen Inc. Stock, NASDAQ:AXGN

13631 Progress Boulevard, Suite 400, Alachua, Florida 32615

United States of America

Phone: +1.386.462.6800

Number of Employees: 428

http://www.axogeninc.com

Description

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firmÃ¢â?¬â?¢s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.